Mind Medicine Inc (NASDAQ:MNMD) has a beta value of 2.37 and has seen 1.71 million shares traded in the last trading session. The company, currently valued at $474.82M, closed the last trade at $6.30 per share which meant it lost -$0.53 on the day or -7.76% during that session. The MNMD stock price is -93.97% off its 52-week high price of $12.22 and 20.16% above the 52-week low of $5.03.
The consensus among analysts is that Mind Medicine Inc (MNMD) is Buy stock at the moment, with a recommendation rating of 1.09. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.37.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Sporting -7.76% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the MNMD stock price touched $6.30 or saw a rise of 8.83%. Year-to-date, Mind Medicine Inc shares have moved -9.48%, while the 5-day performance has seen it change 3.79%. Over the past 30 days, the shares of Mind Medicine Inc (NASDAQ:MNMD) have changed -29.77%.
Wall Street analysts have a consensus price target for the stock at $15, which means that the shares’ value could jump 58.0% from current levels. The projected low price target is $14.0 while the price target rests at a high of $16.0. In that case, then, we find that the current price level is -153.97% off the targeted high while a plunge would see the stock gain -122.22% from current levels.
Mind Medicine Inc (MNMD) estimates and forecasts
The company’s shares have gained 2.69% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 12.11% over the past 5 years. Earnings growth for 2025 is a modest -2.36% while over the next 5 years, the company’s earnings are expected to increase by 8.04%.
MNMD Dividends
Mind Medicine Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Also the top two Mutual Funds that are holding company’s shares are iShares Russell 2000 ETF and Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 2.87% shares in the company for having 2.17 shares of worth $13.65 million while later fund manager owns 988.95 shares of worth $6.23 million as of Dec 31, 2024 , which makes it owner of about 1.31% of company’s outstanding stock.
